Soleno Therapeutics (SLNO) Divestments (2016 - 2017)
Soleno Therapeutics' (SLNO) quarterly Divestments came in at $717000.0 in Q3 2017, up 35750.0% year-on-year from N/an in Q3 2016, and up 23800.0% on a QoQ basis from $3000.0 in Q2 2017.
Soleno Therapeutics (SLNO) Divestments (2016 - 2017) Analysis & Trends
Soleno Therapeutics (SLNO) has 2 years of Divestments data on file, last reported at $717000.0 in Q3 2017.
- On a quarterly basis, Divestments rose 35750.0% year-over-year to $717000.0 in Q3 2017; TTM through Dec 2017 was $716000.0, a N/A change from a year earlier, with the FY2018 full-year figure at -$172000.0, down 124.02% from the prior year.
- Divestments for Q3 2017 stood at $717000.0, up from $3000.0 in the prior quarter.
- Over the last five years, Divestments for SLNO reached as high as $717000.0 in Q3 2017 and fell as low as -$6885.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 717,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | -4,000.00 |
| Dec 31, 2016 | -6,885.00 |
| Sep 30, 2016 | 2,000.00 |